A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosisAlessandro M. Vannucchi, Jason Gotlib, F. Cervantes et al.|Haematologica|2015Cited by 252
Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion–Positive CancerAlison M. Schram, Alexander Drilon, Kōichi Goto et al.|New England Journal of Medicine|2025Cited by 104